EMEA-000406-PIP01-08-M04

Key facts

Invented name
Ivemend
Active substance
fosaprepitant
Therapeutic area
Oncology
Decision number
P/0010/2014
PIP number
EMEA-000406-PIP01-08-M04
Pharmaceutical form(s)
Powder for solution for infusion
Condition(s) / indication(s)
Prevention of nausea and vomiting
Route(s) of administration
Intravenous use
Contact for public enquiries
Merck Sharp & Dohme Ltd
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000406-PIP01-08-M04
Compliance opinion date
10/10/2014
Compliance outcome
positive

Decision

How useful was this page?

Add your rating